Sorrento Therapeutics (NASDAQ:SRNE) Earns Hold Rating from Analysts at initiated coverage on shares of Sorrento Therapeutics (NASDAQ:SRNEFree Report) in a report released on Sunday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock.

Sorrento Therapeutics Price Performance

Shares of SRNE stock opened at $0.02 on Friday. The firm’s 50 day moving average price is $0.02 and its two-hundred day moving average price is $0.05. Sorrento Therapeutics has a 52-week low of $0.00 and a 52-week high of $0.42.

About Sorrento Therapeutics

(Get Free Report)

Sorrento Therapeutics, Inc engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates.

Featured Stories

Receive News & Ratings for Sorrento Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sorrento Therapeutics and related companies with's FREE daily email newsletter.